Common Stock, Shares Authorized of Seres Therapeutics, Inc. from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Seres Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2014 to Q3 2025.
  • Seres Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 360M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Seres Therapeutics, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 360M 0 0% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 360M 0 0% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 360M +120M +50% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 360M +120M +50% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 360M +120M +50% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 360M +120M +50% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 240M +40M +20% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 240M +40M +20% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 240M +40M +20% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 240M +40M +20% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 200M 0 0% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 200M 0 0% 31 Dec 2022 8-K 15 Aug 2024
Q3 2022 200M 0 0% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 200M 0 0% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 200M 0 0% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 200M 0 0% 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 200M 0 0% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 200M 0 0% 30 Jun 2021 10-Q 03 Aug 2021
Q1 2021 200M 0 0% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 200M 0 0% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 200M 0 0% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 200M 0 0% 30 Jun 2020 10-Q 28 Jul 2020
Q1 2020 200M 0 0% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 200M 0 0% 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 200M 0 0% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 200M 0 0% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 200M 0 0% 31 Mar 2019 10-Q 02 May 2019
Q4 2018 200M 0 0% 31 Dec 2018 10-K 02 Mar 2020
Q3 2018 200M 0 0% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 200M 0 0% 30 Jun 2018 10-Q 02 Aug 2018
Q1 2018 200M 0 0% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 200M 0 0% 31 Dec 2017 10-K 06 Mar 2019
Q3 2017 200M 0 0% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 200M 0 0% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 200M 0 0% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 200M 0 0% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 200M 0 0% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 200M +135M +208% 30 Jun 2016 10-Q 11 Aug 2016
Q1 2016 200M 31 Mar 2016 10-Q 16 May 2016
Q4 2015 200M +162M +426% 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 200M 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 65M 30 Jun 2015 10-Q 10 Aug 2015
Q4 2014 38M 31 Dec 2014 10-K 08 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.